Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Exagen Inc (XGN)
NASDAQ:XGN
Exagen (XGN) Stock Price & Analysis
74 Followers
XGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.04 - $8.96
Previous Close$3.15
Volume868.00
Average Volume (3M)19.33K
Market Cap
$53.34M
Enterprise Value$35.45M
Total Cash (Recent Filing)$52.18M
Total Debt (Recent Filing)$34.63M
Price to Earnings (P/E)-1.2
Beta0.88
Next Earnings
Aug 02, 2023EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.61
Shares Outstanding16,825,696
10 Day Avg. Volume5,327
30 Day Avg. Volume19,327
Standard Deviation0.18
R-Squared0.15
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.07
Price to Sales (P/S)4.72
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.76
Enterprise Value/Gross Profit1.66
Enterprise Value/Ebitda-0.84
Forecast
1Y Price Target
$5.50Price Target Upside73.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Exagen News
Press ReleasesExagen Inc. Reports First Quarter 2023 Results
Press ReleasesExagen Inc. to Participate in Upcoming March Conferences
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
XGN FAQ
What was Exagen Inc’s price range in the past 12 months?
Exagen Inc lowest stock price was $2.04 and its highest was $8.96 in the past 12 months.
What is Exagen Inc’s market cap?
Currently, no data Available
When is Exagen Inc’s upcoming earnings report date?
Exagen Inc’s upcoming earnings report date is Aug 02, 2023 which is in 55 days.
How were Exagen Inc’s earnings last quarter?
Exagen Inc released its earnings results on May 15, 2023. The company reported -$0.44 earnings per share for the quarter, beating the consensus estimate of -$0.562 by $0.122.
Is Exagen Inc overvalued?
According to Wall Street analysts Exagen Inc’s price is currently Undervalued.
Does Exagen Inc pay dividends?
Exagen Inc does not currently pay dividends.
What is Exagen Inc’s EPS estimate?
Exagen Inc’s EPS estimate is -$0.5.
How many shares outstanding does Exagen Inc have?
Exagen Inc has 16,825,697 shares outstanding.
What happened to Exagen Inc’s price movement after its last earnings report?
Exagen Inc reported an EPS of -$0.44 in its last earnings report, beating expectations of -$0.562. Following the earnings report the stock price went up 19.588%.
Which hedge fund is a major shareholder of Exagen Inc?
Among the largest hedge funds holding Exagen Inc’s share is Platinum Investment Management. It holds Exagen Inc’s shares valued at N/A.
---
Exagen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.50 (73.50% Upside)
$5.50 (73.50% Upside)
Hedge Fund Trend
Decreased
By 264.1K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
-48.36%
12-Months-Change
Fundamentals
Return on Equity
-79.94%
Trailing 12-Months
Asset Growth
-35.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Exagen Inc
Exagen Diagnostics Inc was incorporated under the laws of the state of New Mexico in 2002. The Company is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets four products under its Avise brand to provide an accurate, timely and differential diagnosis and to optimize the treatment of ARDs. It processed approximately 9,300 patient specimens for its diagnostic product line, Avise SLE. It markets and sells solutions to community rheumatologists.
---
Top 5 ETFs holding XGN
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold XGN. The ETFs are listed according to market value of XGN within the ETF
---
---